Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor
Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
Pharma News

Ipsen’s Cabometyx recommended by NICE for previously treated HCC

Pharma News

UK digital health firms join together on stroke care platform

Pharma News

Clovis warns of insolvency as Rubraca goes into reverse

Pharma News

Nordic Nanovector to merge with APIM after Betalutin fail

Pharma News

‘Healthcare shouldn’t be about treatment’: are diagnostics the answer to ending disease...

Pharma News

The power of patient perspectives in the publication of real-world studies

Pharma News

FDA panel backs AZ’s PT027 asthma rescue drug, but in adults only

Pharma News

NRG announces £16m Series A for IND for Parkinson’s and ALS

Pharma News

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part...

Pharma News

FDA blocks early filing for ADC drug, signalling tougher stance

Pharma News

GSK plans phase 3 for hepatitis B drug bepirovirsen, despite efficacy drop

Pharma News

Sanofi signs $1.2bn research alliance with AI specialist Insilico

Latest news

  • Pharma News

    Pfizer plans considerable 2023 Comirnaty markup

    by Stephen Riddle October 24, 2022
    by Stephen Riddle October 24, 2022

    With US government supplies of Covid vaccines predicted to run out in the first quarter…

    Read more
  • Pharma News

    BMS lines up follow-up indication for cardiomyopathy drug Camzyos

    by Stephen Riddle October 24, 2022
    by Stephen Riddle October 24, 2022

    Bristol-Myers Squibb is going after a second indication for its first-to-market cardiac myosin inhibitor Camzyos,…

    Read more
  • Pharma News

    Trying to get clarity on CDF and VPAS and implications for the IMF

    by Stephen Riddle October 24, 2022
    by Stephen Riddle October 24, 2022

    Companies who are thinking about seeking funding via England’s new Innovative Medicines Fund (IMF) need…

    Read more
  • Pharma News

    Medicines Patent Pool, Novartis pen deal to boost access to generic leukaemia drug

    by Stephen Riddle October 21, 2022
    by Stephen Riddle October 21, 2022

    The Medicines Patent Pool (MPP) and Novartis have unveiled a new voluntary licensing agreement to…

    Read more
  • Pharma News

    AbbVie acquires DJS for $255m cash, fortifies immunology pipeline

    by Stephen Riddle October 21, 2022
    by Stephen Riddle October 21, 2022

    The acquisition of DJS Antibodies, a privately-held UK-based biotechnology company dedicated to discovering and developing…

    Read more
  • Pharma News

    Roche, Hookipa Pharma agree $25 million deal for arenaviral immunotherapy

    by Stephen Riddle October 21, 2022
    by Stephen Riddle October 21, 2022

    Swiss pharma giant Roche has moved to strengthen its position in the KRAS-mutated cancer space…

    Read more
  • Pharma News

    Text message therapy for depression works in young adults

    by Stephen Riddle October 21, 2022
    by Stephen Riddle October 21, 2022

    Young adults with depression have been treated effectively with a cognitive behavioural therapy (CBT) course…

    Read more
  • Pharma News

    GSK continues campaign for greater adult immunisation coverage

    by Stephen Riddle October 21, 2022
    by Stephen Riddle October 21, 2022

    The UK company reveals the results from a partner-led survey to discover the rates of…

    Read more
  • Pharma News

    Frontiers Health 2022 – day 2

    by Stephen Riddle October 21, 2022
    by Stephen Riddle October 21, 2022

    And the LIVE coverage continues as we head into Day Two… This day is set…

    Read more
  • Pharma News

    At ESMO 2022, oncologists saw exciting cancer advances

    by Stephen Riddle October 20, 2022
    by Stephen Riddle October 20, 2022

    Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to…

    Read more
  • Pharma News

    Live from Reuters Pharma 2022 – the pharmaphorum podcast

    by Stephen Riddle October 20, 2022
    by Stephen Riddle October 20, 2022

    In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to…

    Read more
  • Pharma News

    BMA responds to ABPI report, warns UK losing research leadership

    by Stephen Riddle October 20, 2022
    by Stephen Riddle October 20, 2022

    In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a…

    Read more
  • Pharma News

    Achieving commercial excellence with data-driven decisions

    by Stephen Riddle October 20, 2022
    by Stephen Riddle October 20, 2022

    Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that…

    Read more
  • Pharma News

    Frontiers Health 2022 – day 1

    by Stephen Riddle October 20, 2022
    by Stephen Riddle October 20, 2022

    Frontiers Health 2022 in Milan is LIVE! Opening Day One will be Healthware Group’s CEO…

    Read more
  • Pharma News

    Jazz and Zymeworks enter exclusive zanidatamab agreement

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Jazz Pharmaceuticals and Zymeworks, Inc. have announced that Jazz and Zymeworks BC, Inc. (a Zymeworks…

    Read more
  • Pharma News

    Nucleome raises £37.5m to shine light on ‘dark genome’

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    UK biotech Nucleome Therapeutics has been thrust into the spotlight thanks to a £37.5 million…

    Read more
  • Pharma News

    What CVS’s Signify Health acquisition means for the future of healthcare

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    CVS Health recently acquired home healthcare agency, Signify Health, for a whopping $8 billion. With…

    Read more
  • Pharma News

    NICE says yes to Grifols’ Tavlesse for rare blood disorder ITP

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Patients across the UK with chronic immune thrombocytopenia (ITP) now have another treatment option, after…

    Read more
  • Pharma News

    How the Digital Patient Experience is Shaping the Future of Pharma

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly…

    Read more
  • Pharma News

    Battling breast cancer with precision medicine

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Image: Laura Holmes Haddad It was the summer of 2012 and I had just turned…

    Read more
  • Pharma News

    Phesi launches AI-driven trial accelerator, saving $7m per trial

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Yesterday, global provider of patient-centric data analytics, Phesi launched its AI-driven Trial Accelerator Platform, an…

    Read more
  • Pharma News

    Synlogic preps phenylketonuria drug for phase 3 after mid-stage win

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic…

    Read more
  • Pharma News

    Chiesi joins with Aptar on digital platform for respiratory patients

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Hard on the heels of the official launch of its digital disease management platform, Aptar…

    Read more
  • Pharma News

    Every scientific message has a story. Medical communications must adapt to effectively bring these to life.

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Medical communications are in a state of transition. Due to the combined impact of emerging…

    Read more
  • Pharma News

    Amplifying HCP engagement using modular content

    by Stephen Riddle October 19, 2022
    by Stephen Riddle October 19, 2022

    Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the…

    Read more
  • Pharma News

    Lilly nabs another gene therapy firm, buying hearing loss player Akouos

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    Eli Lilly has agreed to buy hearing loss gene therapy developer Akouos in a deal…

    Read more
  • Pharma News

    BD partners with Biocorp on connected self-injection devices

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the…

    Read more
  • Pharma News

    Frontiers Health Steering Committee spotlight – Monique Levy

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    As the Frontiers Health 2022 conference in Milan on 20th to 21st October approaches this…

    Read more
  • Pharma News

    Oculis SA and EBAC join to drive ophthalmology innovation

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye…

    Read more
  • Pharma News

    GSK turns to AI specialist Tempus for R&D productivity boost

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    One of the first actions by GSK’s recently-appointed chief scientific officer Tony Wood has been…

    Read more
  • Pharma News

    Gilead pledges $1.76bn to MacroGenics for bispecific cancer antibody

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    Gilead Sciences has made yet another rush into the oncology category, licensing a bispecific antibody…

    Read more
  • Pharma News

    Roche Q3 results show steep fall-off in COVID product sales

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    Roche’s third-quarter results have revealed a clear sign that the bumper sales boosting companies that…

    Read more
  • Pharma News

    Key operational considerations to optimise decentralised clinical trials

    by Stephen Riddle October 18, 2022
    by Stephen Riddle October 18, 2022

    Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience…

    Read more
  • Pharma News

    FDA delays decision on Biogen’s ALS hope tofersen

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    The FDA is planning to take an additional three months to review Biogen’s experimental therapy…

    Read more
  • Pharma News

    Company Profile: Viseven

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    This post was originally published on Source Link

    Read more
  • Pharma News

    Novo Nordisk launches recycling programme for pen injectors

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    There’s no doubt that self-injection devices have transformed the lives of people with chronic diseases…

    Read more
  • Pharma News

    Bayer extends elinzanetant trials to include breast cancer

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    Bayer has added another clinical trial to its extensive phase 3 programme for oral neurokinin…

    Read more
  • Pharma News

    Takeda dengue vaccine receives positive CHMP opinion

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted…

    Read more
  • Pharma News

    Atara closes on first approval of transplant complication therapy

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    Atara Biotherapeutics’ cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease…

    Read more
  • Pharma News

    Novartis facing Gilenya generics again as Supreme Court lifts stay

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    Novartis’ hopes that the Supreme Court would protect its big-selling multiple sclerosis drug Gilenya from…

    Read more
  • Pharma News

    Bringing the promise of immunotherapy to a broader population

    by Stephen Riddle October 17, 2022
    by Stephen Riddle October 17, 2022

    When James P Allison and Tasuku Honjo were awarded the Nobel Prize for Medicine in…

    Read more
  • Pharma News

    Gene therapies for prevalent diseases in Europe – the perfect storm of economic sustainability?

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    In this article, Research Partnership reviews why the path to commercialisation for the half a…

    Read more
  • Pharma News

    Bayer get EU nod for extended use of contraceptive Mirena

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    Bayer’s big-selling contraceptive Mirena has been approved in Europe to provide up to eights years…

    Read more
  • Pharma News

    Odyssey Therapeutics $168 million Series B financing oversubscribed

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing, led by…

    Read more
  • Pharma News

    Janssen leads effort to cut waste in digital health devices

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division…

    Read more
  • Pharma News

    Otonomy’s hearing loss drug shows no benefit in trial, tanking shares

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    Otonomy has chalked up its second clinical trial failure in the space of a few…

    Read more
  • Pharma News

    Reuters Pharma 2022 – Day 3 coverage

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    Day 3 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview Click here…

    Read more
  • Pharma News

    6th Antifibrotic Drug Development Summit

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    As the only industry-led forum providing biopharma with the insights necessary to make strategic and…

    Read more
  • Pharma News

    Top things to avoid when seeking to separate professionally

    by Stephen Riddle October 14, 2022
    by Stephen Riddle October 14, 2022

    Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional,…

    Read more
  • Pharma News

    US clears Omicron shots from Pfizer, Moderna for children

    by Stephen Riddle October 13, 2022
    by Stephen Riddle October 13, 2022

    The US authorities have authorised use of two bivalent COVID-19 booster vaccines from Pfizer/BioNTech and…

    Read more
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 49

Recent Posts

  • Ipsen’s Cabometyx recommended by NICE for previously treated HCC

    November 10, 2022
  • UK digital health firms join together on stroke care platform

    November 10, 2022
  • Clovis warns of insolvency as Rubraca goes into reverse

    November 10, 2022
  • Nordic Nanovector to merge with APIM after Betalutin fail

    November 10, 2022
  • ‘Healthcare shouldn’t be about treatment’: are diagnostics the answer to ending disease and virus outbreaks?

    November 10, 2022
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor

@2018 - TopPharmaNews.com. All Right Reserved.